SCHEMBL1701174

SCHEMBL1701174

CCC1CNCCN1CCS(=O)(=O)O

nearest known ligand 0.40

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.34
CA1 P00915 4/20 0.32
CA2 P00918 4/20 0.32
CA4 P22748 4/20 0.32
CA9 Q16790 4/20 0.32
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
ADRB1 P08588 1/20 0.30
SMYD3 Q9H7B4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21358777 0.91 TAAR1 (0.35) TAAR1CA1CA2CA4CA9
SCHEMBL62392 0.86 CA1 (0.35) TAAR1CA1CA2CA4CA9
SCHEMBL83681 0.83 CA1 (0.44) TAAR1CA1CA2CA4CA9
SCHEMBL3110597 0.79 TAAR1 (0.43) TAAR1TDP1L3MBTL1
Acetonitrile SCHEMBL28171050 0.79 CA1 (0.40) TAAR1CA1CA2CA4CA9
SCHEMBL9567014 0.79 LMNA (0.31)
SCHEMBL9559747 0.78 TAAR1 (0.37) TAAR1CA1CA2CA4CA9
Hydrochloric Acid SCHEMBL28058920 0.78 TAAR1 (0.42) TAAR1TDP1L3MBTL1
Hydrochloric Acid SCHEMBL28058916 0.78 TAAR1 (0.42) TAAR1TDP1L3MBTL1
SCHEMBL27824766 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009076645-A1 METHOD FOR NUCLEIC ACIDS ISOLATION PROGENTECH USA, INC. (US) 2009-06-18 WO claimed
WO-2024151503-A1 TREATMENT OF SKIN DISORDERS WITH SHORT CHAIN FATTY ACIDS TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2024-07-18 WO disclosed
EP-4392045-A1 IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM American Regent, Inc. (US) 2024-07-03 EP disclosed
EP-4388319-A1 PERSONALIZED MODULATION THERAPY FOR CANCER Faeth Therapeutics, Inc. (US) 2024-06-26 EP disclosed
EP-4384498-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER Onconova Therapeutics, Inc. (US) 2024-06-19 EP disclosed
WO-2024124014-A1 COMPOSITIONS FOR PRE-SURGICAL NUTRITIONAL SUPPLEMENTS TM Nutrition LLC (US) 2024-06-13 WO disclosed
WO-2024107955-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER ONCONOVA THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed
EP-4337092-A1 REAL-TIME PREDICTION OF TISSUE FIXATION TIME Ventana Medical Systems, Inc. (US) 2024-03-20 EP disclosed
WO-2024046992-A1 IMPROVEMENTS TO NEXT-GENERATION TARGET ENRICHMENT PERFORMANCE F. HOFFMANN-LA ROCHE AG (CH) 2024-03-07 WO disclosed
EP-4314330-A1 HYBRIDIZATION BUFFER FORMULATIONS F. Hoffmann-La Roche AG (CH) 2024-02-07 EP disclosed
WO-2021148488-A2 MICROFLUIDIC BEAD TRAPPING DEVICES AND METHODS FOR NEXT GENERATION SEQUENCING LIBRARY PREPARATION F. HOFFMANN-LA ROCHE AG (CH) 2021-07-29 WO disclosed
EP-3728288-A1 METHODS FOR ENHANCED REMOVAL OF IMPURITIES DURING PROTEIN A CHROMATOGRAPHY Genzyme Corporation (US) 2020-10-28 EP disclosed
WO-2020154608-A1 METHOD FOR TREATING IDIOPATHIC PULMONARY FIBROSIS NUMEDII, INC. (US) 2020-07-30 WO disclosed
EP-3463414-A2 PROTEIN INTERFACES Synthex, Inc. (US) 2019-04-10 EP disclosed
WO-2017205852-A2 PROTEIN INTERFACES SYNTHEX, INC. (US) 2017-11-30 WO disclosed
WO-2015084572-A1 FORMULATION AND STORAGE METHOD TO ENHANCE THE ENZYME AND SENSOR STABILITIES GOOGLE INC. (US) 2015-06-11 WO disclosed
WO-2015081197-A1 ADJUSTMENT OF SENSOR SENSITIVITY BY CONTROLLING COPOLYMER FILM THICKNESS THROUGH A CONTROLLED DRYING STEP GOOGLE INC. (US) 2015-06-04 WO disclosed
WO-2014164954-A1 ELECTROCHEMICAL METHOD FOR SYNTHESIZING METAL-CONTAINING PARTICLES AND OTHER OBJECTS UT-BATTELLE, LLC (US) 2014-10-09 WO disclosed
EP-2588027-A1 BIOMATRIX SCAFFOLDS FOR INDUSTRIAL SCALE DISPERSAL The University Of North Carolina At Chapel Hill (US) 2013-05-08 EP disclosed
WO-2012003463-A1 BIOMATRIX SCAFFOLDS FOR INDUSTRIAL SCALE DISPERSAL THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-01-05 WO disclosed